Revolutionary Breakthrough: TRX103’s FDA Clearance Pioneers Allogeneic T-Cell Therapy for Autoimmune Diseases April 10, 2024 Read More »
Revolutionizing ALS Treatment: BrainStorm’s Phase 3b Trial Moves Forward with FDA Approval April 9, 2024 Read More »
Revolutionizing Recovery: The Dawn of Stem Cell Therapy for Spinal Cord Injuries April 8, 2024 Read More »
